The First Affiliated Hospital Of Zhengzhou University

This study tests whether combining the experimental drug ivoximab with the chemotherapy temozolomide is safe and effective for people whose glioma (a type of brain tumor) has come back or stopped responding to treatment. About 29 adults will receive the drug combination and be mo…

This study tests whether adding extra drugs to standard chemo-immunotherapy can help people with advanced stomach cancer. About 78 adults with non-surgical or metastatic stomach cancer will receive SHR1701 plus chemotherapy, along with either an EZH2 inhibitor or an anti-angiogen…

This study compares two treatments for people with completely blocked heart arteries (chronic total occlusions). One uses a drug-coated balloon to open the blockage, sometimes with a stent; the other uses a stent alone. The goal is to see if the balloon approach works as well or …

This study will follow 15,000 adults with chronic hepatitis B across 200 hospitals in China. Researchers will look at how different treatments affect liver cancer rates and other health outcomes. The goal is to find the best ways to manage the disease and work toward a cure.